Kerala High Court Affirms Centre's Authority to Address High Prices of Patented Cancer Drugs
The Kerala High Court ruled that the Central government has the legal authority under Section 100 of the Patents Act, 1970, to manufacture or authorize production of patented life-saving medicines for needy patients at non-commercial rates when prices are exorbitant. The case originated from a breast cancer patient seeking affordable access to Ribociclib, a costly patented drug. While the court affirmed government power to intervene, it left the decision to invoke this power to the Centre after collecting data on affordability and patient needs, without mandating immediate action.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (57/100). Lens Score 62/100.
Outlets measured: ndtv, thehindu. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (62–62/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thehindu broke this story on 28 Sept, 06:53 am. Other outlets followed.
- 1